Razuprotafib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target receptor-type tyrosine-protein phosphatase beta.
Trade Name |
|
Common Name |
Razuprotafib |
Indication |
|
Drug Class |
Protein tyrosine phosphatase 1B inhibitors |